“CC#139511: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Phase

Division (Location)

Study ID

NCT#

Brief Description
“CC#139511: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.